RS

Rekha Singh

Active Director Director DIN 08919902
DIN 08919902 First appointment Oct 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Rekha Singh

Data last updated:

Rekha Singh is a Director at Wbl Pharma Private Limited (since 2020). The company operates in Chemicals. Wbl Pharma Private Limited reported revenue of ₹29.7 Lakh (FY 2024).

DIN 08919902
Primary Designation Director
Industry Chemicals
First Appointment 15 Oct 2020
Oldest Company Age 6 yrs
Largest company Wbl Pharma Private Limited · ₹29.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wbl Pharma Private Limited U24230UP2020PTC136288
Director15 Oct 20202020₹29.7 Lakh (FY 2024)Active

Board colleagues of Rekha Singh

NameDINCompanyDesignation
Servendra Kumar Singh07191140Wbl Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wbl Pharma Private Limited
Premium access

Shareholding and investment profile for Rekha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Singh

Rekha Singh currently holds 1 directorship: Wbl Pharma Private Limited (Director, since 15 Oct 2020, revenue ₹29.7 Lakh (FY 2024)).

Rekha Singh was first appointed on 15 Oct 2020 as Director at Wbl Pharma Private Limited.

The current boards of Rekha Singh's companies include Servendra Kumar Singh (Wbl Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available